Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Mar Drugs ; 18(5)2020 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-32397584

RESUMEN

The inhibitory effects of carrageenans (CRGs) on lipopolysaccharide (LPS) induced inflammation in a mouse model of endotoxemia and in complex therapy of patients with enteric infections of Salmonella etiology were studied. The atomic force microscopy (AFM) examination of LPS and its mixture with CRGs showed that the LPS morphology is significantly changed under the action of κ- and κ/ß-CRGs. CRGs were able to increase the synthesis of anti-inflammatory interleukin 10 (IL-10) in vitro, and, at low concentrations, their activity in the mixture with LPS was higher. The protective effect of CRGs against Escherichia coli LPS was studied in vivo by monitoring the biochemical and pathomorphological parameters. The κ- and κ/ß-CRGs and food supplement "Carrageenan-FE" increased the nonspecific resistance of mice to E. coli LPS at the expense of the inhibition of processes of thymus involution, adrenals hypertrophy, thyroid atrophy, hypercorticoidism, glycogenolysis, and lactate acidosis. The estimation of the therapeutic action of food supplement Carrageenan-FE in complex therapy of patients with enteric infections of Salmonella etiology is given. Carrageenan-FE restores the system of hemostasis and corrects some biochemical indicators and parameters in the immune systems of patients. These results allow us to hope for the practical application of CRGs for lowering the endotoxemia level in patients under the development of the infectious process caused by Gram-negative bacteria.


Asunto(s)
Carragenina/administración & dosificación , Suplementos Dietéticos , Endotoxemia/dietoterapia , Infecciones por Escherichia coli/tratamiento farmacológico , Intoxicación Alimentaria por Salmonella/dietoterapia , Animales , Carragenina/aislamiento & purificación , Modelos Animales de Enfermedad , Endotoxemia/inmunología , Infecciones por Escherichia coli/inmunología , Humanos , Lipopolisacáridos/antagonistas & inhibidores , Lipopolisacáridos/inmunología , Lipopolisacáridos/toxicidad , Masculino , Ratones , Rhodophyta/química , Salmonella/aislamiento & purificación , Intoxicación Alimentaria por Salmonella/sangre , Intoxicación Alimentaria por Salmonella/inmunología , Intoxicación Alimentaria por Salmonella/microbiología
2.
J Virol Methods ; 271: 113674, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31170468

RESUMEN

Lassa fever is a severe viral hemorrhagic illness caused by Lassa virus. Based on estimates, the number of LASV infections ranges from 300,000 to 500,000 cases in endemic areas with a fatality rate of 1%. Development of fast and sensitive tools for the control and prevention of Lassa virus infection as well as for clinical diagnostics of Lassa fever are crucial. Here we reported development and evaluation of a one-step quantitative RT-qPCR assay for the Lassa virus detection - LASV-Fl. This assay is suitable for the detection of lineages I-IV of Lassa virus. The limit of detection of the assay ranged from 103 copies/ml to 105 copies/ml and has 96.4% diagnostic sensitivity, whereas analytical and diagnostic specificities both were 100%. Serum, whole blood and tissue are suitable for use with the assay. The assay contains all the necessary components to perform the analysis, including an armored positive control (ARC+) and an armored internal control (IC). The study was done during the mission of specialized anti-epidemic team of the Russian Federation (SAET) in the Republic of Guinea in 2015-2018. Based on sequencing data, LASV-specific assay was developed using synthetic MS2-phage-based armored RNA particles, RNA from Lassa virus strain Josiah, and further, evaluated in field conditions using samples from patients and Mastomys natalensis rodents.


Asunto(s)
Fiebre de Lassa/diagnóstico , Virus Lassa/aislamiento & purificación , ARN Viral/aislamiento & purificación , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Adolescente , Adulto , Animales , Niño , Cartilla de ADN/genética , Sondas de ADN/genética , Femenino , Guinea , Humanos , Fiebre de Lassa/sangre , Límite de Detección , Masculino , Persona de Mediana Edad , Murinae/virología , Sensibilidad y Especificidad , Adulto Joven
3.
Health Secur ; 16(1): 14-21, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29350545

RESUMEN

Filoviruses are important etiological agents of emergent diseases with high mortality rates. Traditionally, filovirus fever diseases have primarily been a burden of African countries; however, global interconnectedness has increased the probability of the worldwide spread of filoviruses. Therefore, national healthcare organizations need tools for managing filovirus risk, including diagnostic kits based on real-time reverse transcription PCR (RT-qPCR), as this is the most suitable method for diagnosing filovirus fever diseases. Here we describe a real-time RT-qPCR assay for filovirus detection. This assay is a further development of our previously reported EBOV (Zaire)-Fl kit. Two sets (FiloA-Fl and FiloB-Fl) of real-time RT-qPCR assays for the detection of filoviruses were developed and evaluated using armored RNA phage particles (ARs) as positive controls. The limit of detection of the assay was 5x102 copies/ml of the AR-positive control for the FiloA-Fl set and 5x103 copies/ml of the AR-positive control for the FiloB-Fl set. Our assay provides a rapid and sensitive tool for detecting filoviruses. The high specificity and sensitivity of the assay make it useful for clinical and epidemiologic investigations in the field of filovirus fever diseases and their etiological agents.


Asunto(s)
Ebolavirus/aislamiento & purificación , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Ebolavirus/genética , Fiebre Hemorrágica Ebola/diagnóstico , Fiebre Hemorrágica Ebola/virología , Humanos , Pruebas en el Punto de Atención , Sensibilidad y Especificidad
5.
Emerg Infect Dis ; 17(10): 1816-23, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22000350

RESUMEN

Borrelia miyamotoi is distantly related to B. burgdorferi and transmitted by the same hard-body tick species. We report 46 cases of B. miyamotoi infection in humans and compare the frequency and clinical manifestations of this infection with those caused by B. garinii and B. burgdorferi infection. All 46 patients lived in Russia and had influenza-like illness with fever as high as 39.5°C; relapsing febrile illness occurred in 5 (11%) and erythema migrans in 4 (9%). In Russia, the rate of B. miyamotoi infection in Ixodes persulcatus ticks was 1%-16%, similar to rates in I. ricinus ticks in western Europe and I. scapularis ticks in the United States. B. miyamotoi infection may cause relapsing fever and Lyme disease-like symptoms throughout the Holarctic region of the world because of the widespread prevalence of this pathogen in its ixodid tick vectors.


Asunto(s)
Borrelia/aislamiento & purificación , Fiebre Recurrente/diagnóstico , Antibacterianos/uso terapéutico , Anticuerpos Antibacterianos/sangre , Anticuerpos Antibacterianos/inmunología , Borrelia/genética , Borrelia/inmunología , Doxiciclina/uso terapéutico , Humanos , Inmunoglobulina M/sangre , Inmunoglobulina M/inmunología , Filogenia , ARN Ribosómico 16S/genética , Recurrencia , Fiebre Recurrente/tratamiento farmacológico , Fiebre Recurrente/microbiología , Federación de Rusia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...